01 1Hetero Drugs
01 1NABUMETONE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-12-05
Pay. Date : 2013-08-01
DMF Number : 26747
Submission : 2012-12-20
Status : Active
Type : II
20
Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NABUMETONE, with a corresponding US DMF Number 26747.
Remarkably, this DMF maintains an Active status since its submission on December 20, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 05, 2013, and payment made on August 01, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
